Blauvelt, A, RB Warren, K Reich, F Brock, F Fierens, V Ciaravino, and M Lebwohl. “Durability of DLQI Improvements Among Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s19. Accessed April 20, 2024. https://jofskin.org/index.php/skin/article/view/1172.